Gender

7

Review clinical trials related to Gender. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Prospective Multicenter Registry of Gender, Diversity and Inclusion (GEDI) of Women With Acute Coronary Syndrome

Create a multicenter prospective registry that collects information from women affected by acute coronary syndrome (ACS). This registry aims to understand the diversity in the presentation of women with ACS. It proposes to conduct a thorough characterization of the women involved in the study through genetic, biochemical, and molecular analysis.This approach aims to identify any differences in the characteristics of women with ACS and to identify disease subtypes that may influence treatment options and clinical outcomes.

Participants needed: 100
Trial details
Age: 18-100Biological sex: FemaleType: ObservationalSponsor: IRCCS San RaffaeleUpdated: Apr 3, 2026Locations: 4Duration: 12 Months
Eligibility criteria

Women >/= 18 years with ACS (STEMI, NSTEMI or Unstable Angina).

age < 18 years and/or unwillingness to sign informed consent and/or unwillingnes...

Status: Recruiting

Study on Sex-specific, Individualized Dose Calculation of Contrast Agent in CT Examinations

A large proportion of radiological CT examinations require the intravenous administration of iodine-containing X-ray contrast medium. According to current guidelines, the amount required for CT examinations in the (portal) venous phase is calculated on the basis of body weight (e.g. 0.2-0.4 g iodine/kg body weight), but a standardized application dose of the contrast agent is often also used. In earlier studies, the investigators found that the iodine contrast in vessels and organs achieved with a standardized amount of contrast agent differs significantly between women and men. On average, women showed around 10% higher iodine contrast than men of the same height and weight. The investigators attribute these differences to physiological, sex-specific differences in blood volume. For example, the blood volume of a woman 175 cm tall and weighing 75 kg is approx. 400 ml less than that of a man of the same height and weight (approx. 4.6 vs. 5.0 l, calculated according to Nadler). Taking blood volume into account, sex was no longer a significant influencing factor in a retrospective cohort (n=274). The investigators would now like to investigate these results in a prospective study. For this purpose, two groups of patients with a clinical indication for a contrast-enhanced CT scan in the venous phase will be compared: 1. control group with regular weight-adjusted (n = 200) 2. study group with dosing according to blood volume (n = 200). The hypothesis is that the application scheme adapted to the blood volume leads to a more homogeneous contrasting of women and men. In order to quantify this effect, the iodine contrast values of both groups will be quantitatively analyzed, taking into account other influencing variables (height, weight). The investigators hope that this approach will reduce or even eliminate the observed sex-specific differences. This would lead to a sex-equal contrast based on an individualized amount of contrast medium.

Participants needed: 400
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital AugsburgUpdated: Dec 9, 2025Locations: 1
Eligibility criteria

Presence of a justifying indication for a CT scan of the thorax and abdomen with... [+1]

Cardiorespiratory instability (as assessed by the attending physician) [+8]

Status: Recruiting

Barts-MINOCA Registry

The last 15 years the introduction of primary angioplasty has radically improved outcomes for acute myocardial infarction (AMI). However, the system wide availability of prompt investigation has revealed an important group of patients where progress has stalled, the diagnosis is unclear and therapeutic approaches are uncertain. Myocardial infarction with non-obstructive coronary arteries (MINOCA) is found in 1 - 13% of all patients with a clinical diagnosis of AMI. These patients present a therapeutic predicament since coronary revascularization is not appropriate. Guidelines do not exist for their management - yet the condition is not benign - the 12-month prognosis, although better than obstructive coronary artery disease patients is still guarded with recent data suggesting many questions remain unanswered.

Participants needed: 3,000
Trial details
Age: 16+Biological sex: AllType: ObservationalSponsor: Queen Mary University of LondonUpdated: Nov 18, 2025Locations: 1Duration: 5 Years
Eligibility criteria

Both male and female patients ≥16 years of age will be included [+1]

Patients <16 years will not be included in this study.

Status: Not yet recruiting

Impact of Gender Difference and Exercise Intensities on Depression and Anxiety Symptoms Among University Students

This study was done to investigate the impact of gender differences and exercise intensities on depression and anxiety symptoms among university students

Participants needed: 84
Trial details
Age: 18-25Biological sex: AllType: InterventionalSponsor: Cairo UniversityUpdated: Aug 24, 2025Locations: 1
Eligibility criteria

Being a student in higher education [+7]

Neurological history such as illness or head trauma [+5]

Status: Recruiting

Gender Differences and Age Related Differences in Emergency Department Admission

The goal of this observational study is to learn about difference related to age and gender in patients admitted to emergency department.

Participants needed: 15,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCSUpdated: Mar 5, 2025Locations: 1
Eligibility criteria

Age over 18 y [+1]

Age under 18 y

Status: Recruiting

Gender-based Impact on Safety and Efficacy of Lenvatinib in Patients With Differentiated Thyroid Cancer

Lenvatinib is approved for the treatment of radioiodine refractory differentiated thyroid cancer. Despite gender can play a crucial role un in safety and efficacy of oncological product, little is know on gender difference in lenvatinb effacacy and safety in the context of radioiodine refractory differentiated thyroid cancer. The primary objective of the study is to assess safety and toxicity profile in male and female patients in terms of dose reduction. The secondary objectives are to assess sex and gender difference in: the number and the incidence of adverse events; response rate according to RECIST criteria 1.1; progression free survival, overall survival and duration of response.

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Regina Elena Cancer InstituteUpdated: Dec 6, 2024Locations: 1
Eligibility criteria

Patients with refractory iodine DTC treated with lenvatinib [+1]

Status: Not yet recruiting

Building Your Successful Nursing Career

This study aims to evaluate a career planning mobile App specifically tailored for male nurses.This three-year experimental project aims to recruit 120 male nurses (60)in the experimental group and 60 in the control group). Employing a prospective double-blind randomized controlled trial (RCT) design, the study will include six follow-up points (pre-intervention, post-intervention at 0, 6, 12, 18, and 24 months) to examine the effectiveness of career self-efficacy, career adaptive behaviors, occupational resilience, career success, and career continuity intentions of male nurses over time. The repeated measures data will be analyzed with the intention-to-treat analysis method and General Estimating Equations (GEE). This research represents an innovative development of the world's first theoretically grounded career planning mobile App for male nurses.The study's results can serve as a valuable reference for future career planning initiatives in nursing practice and education.

Participants needed: 120
Trial details
Biological sex: MaleType: InterventionalSponsor: Chang Gung Memorial HospitalUpdated: Jul 25, 2024
Eligibility criteria

Male nursing staff currently engaged in clinical nursing work. [+5]

Unwilling to participate in this study. [+1]